Bill Sponsor
Senate Bill 1279
117th Congress(2021-2022)
Medicare at 50 Act
Introduced
Introduced
Introduced in Senate on Apr 21, 2021
Overview
Text
Introduced
Apr 21, 2021
Latest Action
Apr 21, 2021
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1279
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Michigan
Democrat
Illinois
Democrat
Maryland
Democrat
Massachusetts
Democrat
Michigan
Democrat
Minnesota
Democrat
Minnesota
Democrat
New Hampshire
Democrat
New Jersey
Democrat
Pennsylvania
Democrat
Rhode Island
Democrat
Rhode Island
Democrat
Wisconsin
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Medicare at 50 Act

This bill establishes a Medicare buy-in option for certain qualifying individuals and also repeals restrictions relating to prescription drug prices under the Medicare prescription drug benefit.

Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare & Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option.

The bill also repeals provisions that prohibit the CMS from negotiating the prices of prescription drugs or from establishing a formulary under the Medicare prescription drug benefit.

Text (1)
April 21, 2021
Actions (2)
04/21/2021
Read twice and referred to the Committee on Finance.
04/21/2021
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:49:14 PM